...
首页> 外文期刊>Journal of International Medical Research >Anti-Proliferative Effect on Human Pancreatic Cancer Cells of Natural Human Tumour Necrosis Factor-β Combined with Natural Human Interferon-α or Interferon-γ
【24h】

Anti-Proliferative Effect on Human Pancreatic Cancer Cells of Natural Human Tumour Necrosis Factor-β Combined with Natural Human Interferon-α or Interferon-γ

机译:天然人肿瘤坏死因子-β联合天然人干扰素-α或干扰素-γ对人胰腺癌细胞的抗增殖作用

获取原文
           

摘要

The anti-proliferative effects of natural cytokines, human tumour necrosis factor-β, natural human interferon-α and natural human interferon-γ, on three human pancreatic cancer cell lines (PANC-1, MIA PaCa-2 and BxPC-3) were investigated in vitro. The anti-proliferative effect was determined using the dye uptake method and analysed for synergism by the median effect principle. Tumour necrosis factor-β, as a single agent, had little anti-proliferative effect on any of the three cell lines, whereas interferon-α and interferon-γ exhibited a strong anti-proliferative effect against two cell lines (MIA PaCa-2 and BxPC-3) and one cell line (BxPC-3), respectively. When tumour necrosis factor-β and interferon-α were administered together (ratio 1:1), a synergistic effect was observed against PANC-1 cells. The combination of tumour necrosis factor-β and interferon-γ (ratio 10:1) was synergisic against both PANC-1 and MIA PaCa-2 cells. A synergistic anti-proliferative effect of tumour necrosis factor-β and interferons was, therefore, observed even for cell lines that showed little biological response to each cytokine alone. The data suggest that some future improvement in the treatment of pancreatic cancer may be obtained by using combination cytokine therapy.
机译:天然细胞因子,人类肿瘤坏死因子-β,天然人类干扰素-α和天然人类干扰素-γ对三种人类胰腺癌细胞系(PANC-1,MIA PaCa-2和BxPC-3)的抗增殖作用分别为体外调查。使用染料吸收方法确定抗增殖作用,并通过中值作用原理分析协同作用。肿瘤坏死因子-β作为单一药物,对三种细胞系均无抗增殖作用,而干扰素-α和干扰素-γ对两种细胞系均具有很强的抗增殖作用(MIA PaCa-2和BxPC-3)和一个细胞系(BxPC-3)。当肿瘤坏死因子-β和干扰素-α一起给药时(比例为1:1),观察到了对PANC-1细胞的协同作用。肿瘤坏死因子-β和干扰素-γ的组合(比例为10:1)对PANC-1和MIA PaCa-2细胞均具有协同作用。因此,即使对于仅对每种细胞因子几乎没有生物学反应的细胞系,也观察到了肿瘤坏死因子-β和干扰素的协同抗增殖作用。数据表明,通过联合使用细胞因子疗法,可能在胰腺癌的治疗方面取得一些未来的进步。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号